Interrogating the Tumor Microenvironment and Molecular Targets of Immunotherapy: A New Opportunity for Multimodality Imaging
Radiol Imaging Cancer
.
2023 Jul;5(4):e230098.
doi: 10.1148/rycan.230098.
Author
Mark D Pagel
1
Affiliation
1
From the Department of Cancer Systems Imaging, MD Anderson Cancer Center, 1881 East Rd, Rm 3SCR4.3642, Houston, TX 77054-1901.
PMID:
37505108
PMCID:
PMC10413293
DOI:
10.1148/rycan.230098
No abstract available
Publication types
Comment
MeSH terms
Apoptosis
Humans
Hypoxia
Immunotherapy / methods
Ligands
Magnetic Resonance Imaging
Positron-Emission Tomography*
Tumor Microenvironment*
Substances
Ligands
Grants and funding
R01 CA231513/CA/NCI NIH HHS/United States
R01 CA269354/CA/NCI NIH HHS/United States
R43 CA265603/CA/NCI NIH HHS/United States